| Q43000487 | A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect. |
| Q26858776 | Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward |
| Q33403424 | Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors |
| Q33414608 | Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis |
| Q37724644 | Adjuvant chemotherapy for gastric cancer: current evidence and future challenges. |
| Q33378937 | Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. |
| Q44354605 | Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. |
| Q38338980 | Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review |
| Q92557676 | COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis |
| Q34041435 | Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. |
| Q43526800 | Chemoradiotherapy in the adjuvant treatment of gastric adenocarcinomas: real progress? |
| Q26859950 | Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis |
| Q26748744 | Current adjuvant treatment modalities for gastric cancer: From history to the future |
| Q37077239 | Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers. |
| Q26860637 | Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis |
| Q84972214 | Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer |
| Q46339959 | Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. |
| Q82600133 | Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study |
| Q45154773 | Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study |
| Q37079108 | Locally advanced and metastatic gastric cancer: current management and new treatment developments |
| Q84543147 | Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer |
| Q38076028 | Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East |
| Q38072886 | Management of localized gastric cancer |
| Q57845991 | Neoadjuvant Therapy for Gastric Cancer |
| Q37998931 | Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. |
| Q26781043 | Neoadjuvant therapy for gastric cancer: current evidence and future directions |
| Q43459999 | Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy. |
| Q36107240 | Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer |
| Q38169894 | Perioperative chemotherapy in locally advanced gastric cancer. |
| Q36303933 | Perspectives in the treatment of gastric cancer. |
| Q35052015 | Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer |
| Q24198252 | Post-surgical chemotherapy versus surgery alone for resectable gastric cancer |
| Q38226324 | Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis. |
| Q40162858 | Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial. |
| Q36309934 | Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies |
| Q64912272 | Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis. |
| Q48626617 | Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer. |
| Q34479911 | Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. |
| Q36642921 | Reflections on adjuvant treatment of gastric cancer. |
| Q36500558 | Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer |
| Q83839684 | Stomach cancer |
| Q33856530 | Stomach cancer. |
| Q37191090 | Surgery and adjuvant chemotherapy |
| Q58718986 | Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis |
| Q46464172 | Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution |
| Q61795899 | The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis |
| Q36837966 | The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis |
| Q55071100 | The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer. |
| Q27687612 | The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract |
| Q37101403 | The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis |
| Q43245122 | Therapy in gastric cancer. From an oncological perspective |
| Q35688584 | Treatment of resectable gastric cancer |
| Q38247980 | What make differences in the outcome of adjuvant treatments for resected gastric cancer? |
| Q82716750 | [Adjuvant chemotherapy for gastric carcinoma] |